kartik8.bsky.social
@kartik8.bsky.social
Reposted
🎉 scverse conference 2025 Abstracts DEADLINE IN LESS THAN 48 HOURS! 🎉

The deadline to submit abstracts for the scverse Conference 2025 is 11:59PM PST, September 15, 2025!

More information in thread
🧵

#scverse #scverse2025 #SingleCell #Conference
September 14, 2025 at 3:00 PM
Reposted
Meet the keynote speakers for the 2025 scverse conference!
John Marioni, Head of Computation at Genentech Research and Early Development
🧵

@genentech.bsky.social

#scverse #scverse2025 #AI #DrugDevelopment #MachineLearning #ComputationalBiology #Biotech #Genentech #Stanford
August 22, 2025 at 3:02 PM
Reposted
ATTENTION

If you are someone who had an F31-Diversity (or similar) application submitted this cycle, please DM me here, contact me on signal (jeremymberg.78), or email me at [email protected].

I will keep all information confidential.

2/n
February 7, 2025 at 4:06 PM
Reposted
Here we have our TA @kartik8.bsky.social on the Introduction to R session! #evomics2025 #genomics #bioinformatics
January 11, 2025 at 8:27 AM
Reposted
Team photo at the Town Square of Český Krumlov! Ready to start the Workshop on Genomics 2025! #evomics2025 #genomics #bioinformatics
January 5, 2025 at 2:46 PM
Reposted
The workshop team presented themselves in the evening session: Dreams, Fantasy Dreams... and Genomics 💭🧬 We then continued with more activities for the participants to mingle and network! 🙆🏻‍♀️ #evomics2025 #genomics #bioinformatics
January 6, 2025 at 10:05 PM
Reposted
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients

genomemedicine.biomedcentral.com/articles/10....
Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients - Genome Medicine
Background Neoantigen vaccines can induce or enhance highly specific antitumor immune responses with minimal risk of autoimmunity. We have developed a neoantigen DNA vaccine platform capable of effici...
genomemedicine.biomedcentral.com
November 17, 2024 at 3:34 PM